LLLudmila A. Lyapina

Ludmila A. Lyapina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ludmila A. Lyapina has a total of 116 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Regulation of Primary Hemostasis by Peptides with Neuroprotective Effect

    by L. A. Lyapina, M. E. Grigorjeva, T. A. Shubina, T. Yu. Obergan, N. F. Myasoedov

    This review summarizes the current understanding of the antiplatelet effects of glyproline peptides (glyprolins) based on literature data and our own experimental studies. The unique properties of these bioregulators are analyzed, allowing them, along with the main neuroprotective effect in the body, to influence the processes of vascular-platelet hemostasis, which are the main focus of our review. The results of our own studies on PGP, PG, cGP, PGP with the addition of arginine, lysine or leucine, Semax, Selank, KKRRPGP, ACTH(6-9)PGP effects on platelet aggregation activity in normal and metabolic disorders in the body are presented. Generalized data on the properties of the considered peptides led us to conclude that glyprolins have the neuroprotective and antiplatelet effect on the body and to propose their use in clinical practice for the prevention and complex therapy of metabolic disorders.

  • The Corrective Effect of Chitosan on Hemostasis Parameters under Hypocoagulation Conditions Caused by the Antiplatelet Agent Clopidogrel

    by L. A. Lyapina, M. E. Grigorjeva, T. Y. Obergan, T. A. Shubina

    The effect of chitosan in vitro on the blood plasma of healthy rats and rats with acquired bleeding caused by the use of the antiplatelet agent clopidogrel


  • Open Access

    Изучение антикоагулянтных эффектов экстрактов из корней пиона селекционного (Bartzella)

    by Успенская М.с., Ляпина Л.а., Сороколетов С.м., Мурашев В.в., Калугина М.д.

    Введение. Изучение веществ с антикоагулянтными свойствами актуально для физиологии и медицины в связи с широким распространением тромбоопасных состояний в организме человека и животных. Известны растения с подобными эффектами за счет наличия в их тканях молекул полисахаридных гепариноподобных компонентов, которые препятствуют развитию тромбозов. Цель исследования – выявить антикоагулянтные и антиполимеризационные в отношении фибрина эффекты полученного нами экстракта из корней селекционного пиона Bartzella и описать возможные механизмы его действия на экспериментально вызванный тромбоз у крыс. Методика. Исследовано влияние экстракта из селекционного пиона на антикоагулянтную активность плазмы крови крыс тремя тестами – АЧТВ (активированного частичного тромбопластинового времени), ПВ (протромбинового времени), ТВ (тромбинового времени), степень полимеризации фибрина и на процессы растворения фибрина в условиях тромбообразования ex vivo. Использовались лабораторные животные – крысы-самцы линии Wistar. Оценивали фибринолитическую активность плазмы крови крыс по тестам суммарной фибринолитической активности (СФА), неферментативного фибринолиза (НФ), ферментативного фибринолиза (ФФ) на нестабилизированных пластинах фибрина. Полимеризацию фибрина выявляли по тесту фибриндеполимеризационной активности (ФДПА) плазмы крови на нестабилизированном фактором XIIIa фибрине. Результаты. Установлено наличие антикоагулянтных (по удлинению АЧТВ, ТВ, ПВ) и фибринолитических (по усилению СФА, НФ) свойств плазмы после добавления экстракта из гибридного пиона к плазме крови здоровых крыс в соотношении 0.25:1. В условиях ex vivo при моделировании тромбоза у крыс введением животным тканевого тромбопластина (первая модель тромбоза – МТ) добавление к такой плазме крови экстракта из корней пиона Bartzella повышало СФА и НФ на 26 и 45% соответственно. Описаны механизмы активирующего действия экстракта на фибринолиз плазмы вследствие ингибирования тромбина и полимеризации фибрина. На второй МТ ex vivo (в пробирках к плазме крови крыс в объеме 0.2 мл приливали 2 NIH ед. тромбина – 0.05 мл, фибриновый сгусток образовывался в течение 2-3 мин) показано, что экстракт из пиона в объеме 0.1 мл 0.5%-й, добавленный к предобразованному сгустку спустя 15 мин после создания МТ, способен растворять фибрин. Заключение. Установлено, что экстракт из корней селекционного пиона обладал антикоагулянтным и фибриндеполимеризационным эффектами, также при действии на предобразованный нестабилизированный фибрин вызывал растворение свежеобразованных фибриновых сгустков. Описаны механизмы активирующего действия экстракта на фибринолиз плазмы вследствие ингибирования тромбина и полимеризации фибрина. Introduction. Studying substances with anticoagulant properties is relevant for physiology and medicine due to the widespread occurrence of thrombotic conditions in humans and animals. Plants with such effects are known for the presence of anti-thrombotic polysaccharide heparin-like components in their molecular structure. The aim of the study was to identify the anticoagulant and antipolymerization effects on fibrin of the extract obtained from the roots of the breeding peony Bartella and to describe possible mechanisms of its action on experimental ex vivo thrombosis in rats. Methods. The effect of a breeding peony extract on the anticoagulant activity of rat blood plasma was studied using three tests, including activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT), on the degree of fibrin polymerization (DFP) and on the fibrin dissolution in ex vivo thrombosis. Wistar male rats were used for the experiments. The fibrinolytic activity of rat blood plasma was evaluated by tests of total fibrinolytic activity (TFA),...

  • Comparative Studies of Complex Products Based on Heparins of Animal and Plant Origin

    by M. S. Uspenskaya, L. A. Lyapina, S. M. Sorokoletov, M. G. Lyapina, M. D. Kalugina

    Complex preparations based on heparins of animal and vegetable origin with the inclusion of glutamic acid in a weight ratio of 1 : 4 were obtained. High molecular weight (HMН) and low molecular weight (LMH) commercial preparations of heparins were used as heparins of animal origin; heparinoid was used as heparin of plant origin, isolated from the roots of the peony Akademik Sadovnichiy (heparinoid). Their influence on the state of plasma hemostasis under in vitro conditions was studied in a comparative aspect. It has been established that all complex compounds have anticoagulant activity, which, according to the results of our studies, is realized by a different mechanism of their action on blood coagulation—on the internal, external, or general pathways of blood coagulation. HMН complexes with glutamic acid had an antithrombin effect, affecting the internal and general coagulation pathways, while LMH complexes with glutamic acid, exerting anti-Xa activity, affected the internal pathway of coagulation activation, and the combination of heparinoid with glutamic acid inhibited factors of not only internal but also external ways of blood coagulation. In addition, the latter compound exhibited weak antithrombin activity. It was also shown that all heparin complexes prevented fibrin polymerization, increasing the fibrin depolymerization activity of plasma, and in the heparinoid compound, this activity was higher by 10–17% compared to other commercial agents. Thus, the best anticoagulant in terms of efficacy and safety is the heparinoid complex with glutamic acid.

  • Comparative Studies of Complex Products Based on Heparins of Animal and Plant Origin

    by M. S. Uspenskaya, L. A. Lyapina, S. M. Sorokoletov, M. G. Lyapina, M. D. Kalugina

    Complex preparations based on heparins of animal and vegetable origin with the inclusion of glutamic acid in a weight ratio of 1 : 4 were obtained. High molecular weight (HMН) and low molecular weight (LMWH) commercial preparations of heparins were used as heparins of animal origin, heparinoid was used as heparin of plant origin, isolated from the roots of the peony Akademik Sadovnichy (heparinoid). Their influence on the state of plasma hemostasis under in vitro conditions was studied in a comparative aspect. It has been established that all complex compounds have anticoagulant activity, which, according to the results of our studies, is realized by a different mechanism of their action on blood coagulation – on the internal, external, or general pathways of blood coagulation. HMН complexes with glutamic acid had an antithrombin effect, affecting the internal and general coagulation pathways, while LMWH complexes with glutamic acid, exerting anti-Xa activity, affected the internal pathway of coagulation activation, and the combination of heparinoid with glutamic acid inhibited factors not only internal, but also external ways of blood coagulation. In addition, the latter compound exhibited weak antithrombin activity. It was also shown that all heparin complexes prevented fibrin polymerization, increasing the fibrin depolymerization activity of plasma, and in the heparinoid compound, this activity was higher by 10–17% compared to other commercial agents. Thus, the best anticoagulant in terms of efficacy and safety is the heparinoid complex with glutamic acid.

  • Open Access

    Blood fluidity during physical exertion of various types

    by M. E. Grigorjeva, S. M. Sorokoletov, А. В. Коробовский, L. A. Lyapina

    This paper presents data from the literature and own results on the study of blood fluidity (or rheological properties) when performing physical exercises. It is shown that the rheology of blood depends on the functional state of the haemostasis system. It has been established that in the physiological state of the organism, physical exertion of any strength can lead to changes in the reactions of primary and plasma haemostasis and, accordingly, the rheological properties of blood. The review describes the study of factors related to blood flow in humans and animals before and after physical exercise (running, swimming, etc.) in the normal physiological state of the organism, with overstrain and with certain types of pathology (cardiovascular and metabolic diseases). Data on blood flow in conditions of physical activity restriction are presented. Special attention is paid to the corrective role of physical exercises on the rheology (fluidity) of blood in violation of homeostasis of the organism. Possible mechanisms of action of physical exertion on blood flow are considered.


  • The Effect of Chitosan on Blood Coagulation in Heparinized Rats

    by L. A. Lyapina, T. Yu. Obergan, M. E. Grigorjeva, T. A. Shubina

    The chitosan added to heparinized blood plasma in vitro at concentrations of 10–2, 10–1, 1, 5, and 10 mg/mL dose-dependent reduced fibrinolysis, the prothrombin time, platelet aggregation, and blood clotting and increased the activity of factor XIIIa. A decrease in fibrinolysis and plasmin activity and increased FXIIIa activity and platelet aggregation were also detected in vivo in a rat model with hypocoagulation caused by intravenous administration of high-molecular heparin (400 IU/kg of body mass), 30 minutes after injection of chitosan (10 mg/kg of body mass). At the same time, the fibrinogen concentration was restored to the normal levels. It was accompanied by an increase in the activity of the tissue plasminogen activator and an extension of the blood clotting time (APTT test). A conclusion on the multidirectional effect of chitosan on the hemostasis parameters under hypocoagulation was made, and the possible mechanisms of chitosan action were considered.


  • Chitosan Composite with Aspartic Acid and Its Effect on Blood Coagulation In Vitro and In Vivo

    by L. A. Lyapina, M. E. Grigorjeva, T. Y. Obergan, T. A. Shubina

    Composites of chitosan with aspartic acid were created at different weight ratios of components and their effect on the state of primary and plasma hemostasis in vitro was studied in order to identify the most promising of them. Experiments were also carried out on healthy animals with repeated daily oral administration of the detected in vitro coagulant composite chitosan-aspartic acid at a dose of 102 μg/kg of rat body weight for 14 days. It was found that the parameters of primary (platelet aggregation level) and plasma (activated partial thromboplastin time, thrombin time, prothrombin time, fibrinolysis, factor XIIIa level, fibrinogen concentration, fibrin polymerization process) hemostasis indicated an increase in blood coagulation and prevention of hemorrhagic complications in the rats organism 20 h after the last administration of the composite and its components in an equivalent amount. The conclusion is made about the prospects of studying chitosan and its composite with aspartic acid in conditions of pathologically reduced blood coagulation with their subsequent introduction into clinical practice.


  • Open Access

    Pharmacology complex compound of pro-gly-pro-leu with heparin: hypoglycemic, fibrinolitic and anticoagulant effects in rats with hyperglycemia

    by T. Yu. Obergan, N. F. Myasoedov, M. E. Grigorjeva, L. A. Lyapina, T. A. Shubina, L. A. Andreeva

    Комплексное соединение pro-gly-pro-leu с гепарином: гипогликемический, фибринолитический и антикоагулянтный эффекты у крыс с гипергликемией


  • Open Access

    GLYPROLINE PEPTIDE PHARMACODYNAMICS IN RATS IN THE SETTING OF METABOLIC SYNDROME BY THE PARAMETERS OF LIPID METABOLISM AND TROMBOELASTOGRAMMA

    by T. Yu. Obergan, M. G. Lyapina, M. E. Grigorjeva, L. A. Lyapina

    In this study, experimental data on the biological action of glyproline peptides — Pro-Gly-Pro, Pro-ArgPro, Arg-Pro-Gly-Pro and Pro-Gly-Pro-Leu — on the processes of blood coagulation and lipid metabolism were obtained using animal models of metabolic syndrome. Under the conditions of increased blood clotting and hypercholesterolemia, the regulatory peptides under study were administered intranasally for 7 days once every 24 hours. 20 hours after the last peptide administration, thromboelastogram parameters confi rmed the restoration of the functional state of the coagulating and anticoagulant systems. In addition, a simultaneous positive shift in the parameters of lipid metabolism was observed. These changes lasted for 7 days following the withdrawal of the drugs. It is found that the biological action of the peptides under study consists in their simultaneous regulatory impact on the processes of hemostasis and lipid metabolism.